Cefazolin

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Ancef)
Jump to: navigation, search
Image:Cefazolin.png
Cefazolin
Systematic (IUPAC) name
3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-
8-oxo-7-([2-(tetrazol-1-yl)acetyl]amino)- 5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate
Identifiers
CAS number 25953-19-9
ATC code J01DB04
PubChem 33255
Chemical data
Formula C14H13N8O4S3 
Mol. mass 454.51 g/mol
Pharmacokinetic data
Bioavailability NA
Metabolism  ?
Half life 1.8 hours (given IV)
2 hours (given IM)
Excretion Renal, unchanged
Therapeutic considerations
Pregnancy cat.

B1(AU) B(US)

Legal status

Prescription only

Routes Intravenous, intramuscular

WikiDoc Resources for

Cefazolin

Articles

Most recent articles on Cefazolin

Most cited articles on Cefazolin

Review articles on Cefazolin

Articles on Cefazolin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cefazolin

Images of Cefazolin

Photos of Cefazolin

Podcasts & MP3s on Cefazolin

Videos on Cefazolin

Evidence Based Medicine

Cochrane Collaboration on Cefazolin

Bandolier on Cefazolin

TRIP on Cefazolin

Clinical Trials

Ongoing Trials on Cefazolin at Clinical Trials.gov

Trial results on Cefazolin

Clinical Trials on Cefazolin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cefazolin

NICE Guidance on Cefazolin

NHS PRODIGY Guidance

FDA on Cefazolin

CDC on Cefazolin

Books

Books on Cefazolin

News

Cefazolin in the news

Be alerted to news on Cefazolin

News trends on Cefazolin

Commentary

Blogs on Cefazolin

Definitions

Definitions of Cefazolin

Patient Resources / Community

Patient resources on Cefazolin

Discussion groups on Cefazolin

Patient Handouts on Cefazolin

Directions to Hospitals Treating Cefazolin

Risk calculators and risk factors for Cefazolin

Healthcare Provider Resources

Symptoms of Cefazolin

Causes & Risk Factors for Cefazolin

Diagnostic studies for Cefazolin

Treatment of Cefazolin

Continuing Medical Education (CME)

CME Programs on Cefazolin

International

Cefazolin en Espanol

Cefazolin en Francais

Businness

Cefazolin in the Marketplace

Patents on Cefazolin

Experimental / Informatics

List of terms related to Cefazolin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Cefazolin (INN), also known as cefazoline or cephazolin, is a first generation cephalosporin antibiotic.

The drug is usually administrated either by intramuscular injection (injection into a large muscle) or intravenous infusion (intravenous fluid into a vein).

Indications

Cefazolin is mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. These organisms are common on normal human skin. Resistance to cefazolin is seen in several species of bacteria.

Side effects

Side effects from cefazolin are not common. Possible side effects include:

  • diarrhea
  • stomach pain
  • upset stomach
  • vomiting

Cefazolin is marketed under the following brand names: Ancef®, Cefacidal®, Cefamezin®, Cefrina®, Elzogram®, Faxilen®, Gramaxin®, Kefazol®, Kefol®, Kefzol®, Kefzolan®, Kezolin®, Novaporin®, and Zolicef®

External links

fr:Céfazolineth:เซฟาโซลิน de:Cefazolin

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages